medigraphic.com
SPANISH

Investigaciones Medicoquirúrgicas

ISSN 1995-9427 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2023, Number 1

<< Back Next >>

Invest Medicoquir 2023; 15 (1)

Epilepsy secondary to low grade glioma. Presentation of a case

Vega TH, Pérez LK, Silvera RAL
Full text How to cite this article

Language: Spanish
References: 17
Page: 1-14
PDF size: 449.65 Kb.


Key words:

COVID-19, Autoimmune encephalitis, Herpetic encephalitis, Temporal lobe epilepsy, Low-grade malignant glioma, Toxic epidermal necrolysis.

ABSTRACT

Brain tumors constitute a heterogeneous group of neoplasms and, according to the World Health Organization, low-grade gliomas are the most epileptogenic. It is presented a case of a patient with a progressive decrease in the level of consciousness. After performing the complementary tests, two possible diagnoses were proposed. The symptomatology worsened, for which he was transferred to the Intensive Care Unit. During his stay on therapy, prolonged anticonvulsant treatment triggered a rare adverse drug reaction. The definitive diagnosis was made post-mortem. It was concluded that, although the suspicion of this disease was present from the beginning, it was necessary to rule out other pathologies with a similar clinical presentation and the symptomatic treatment of the seizures caused a rare and fatal drug reaction. The specific treatment of the glioma could not be practiced since it was confirmed when the patient died.


REFERENCES

  1. Alegría-Loyola MA, Galnares-Olalde JA, Mercado M. Tumores del sistema nervioso central. Rev Med Inst Mex Seguro Soc [Internet]. 2017 [citado 11/04/2022]; 55(3):330-40. Disponible en: https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.medigraphic.com/pdfs/imss/im-2017/im173i.pdf&ved=2ahUKEwjg1ZuG9o_3AhWzVTABHeLJC6IQFnoECEQQAQ&usg=AOvVaw006FV7NiALjxWVEhCMCwT6

  2. Sierra Benítez EM, León Pérez MQ, Laud Rodríguez L, Carrillo Comas AL, Pérez Ortiz L, Rodríguez Ramos E. Gliomas malignos: biología molecular y detalles oncogenéticos. Rev Méd Electrón [Internet]. 2018 [citado 11/04/2022]; 40(4):1100-1111. Disponible en: http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/2480/3973

  3. Dirección de Registros Médicos y Estadísticos de Salud del MINSAP. Anuario Estadístico de Salud 2020 [Internet]. 49na ed. La Habana, 2021. [citado 11/4/2022]. Disponible en: https://files.sld.cu/bvscuba/files/2021/08/Anuario-Estadistico-Espa%c3%b1ol-2020-Definitivo.pdf

  4. Cornejo Olivas M, Choque Velásquez J, Rivas Franchinni D, Zapata Luyo W, De la Cruz Ramírez W. Epilepsia por glioma de bajo grado de larga evolución. Reporte de un caso. Diagnóstico [Internet]. 2011 [citado 11/04/2022]; 50(4). Disponible en: https://www.researchgate.net/profile/Mario-Cornejo-Olivas/publication/316107748_Epilepsia_por_glioma_de_bajo_grado_de_larga_evolucion_reporte_de_un_caso/links/5fe69a92299bf14088440673/Epilepsia-por-glioma-de-bajo-grado-de-larga-evolucion-reporte-de-un-caso.pdf

  5. Wang TJC, Mehta MP. Low-Grade Glioma. Radiotherapy Treatment and Trials. Neurosurg Clin N Am [Internet]. 2019 [citado 11/04/2022]; 30(1):111–118. Disponible en: https://doi.org/10.1016/j.nec.2018.08.008

  6. Pallud J, McKhann GM. Diffuse Low-Grade Glioma-Related Epilepsy. Neurosurg Clin N Am [Internet]. 2019 [citado 11/04/2022]; 30(1):43-54. Disponible en: https://doi.org/10.1016/j.nec.2018.09.001

  7. Volcy-Gómez M. Epilepsia del lóbulo temporal mesial: fisiopatología, características clínicas, tratamiento y pronóstico. Rev Neurol [Internet]. 2004 [citado 28/04/2022]; 38(7):663-667. Disponible en: https://doi.org/10.33588/rn.3807.2003398

  8. Andueza Urdangarin A, García Gómez S, Frápolli Pérez LM, Guijo Hernández T. Hipodensidad en el lóbulo temporal ¿qué debemos sospechar? Seram [Internet]. 2021 [citado 28/04/2022]; 1(1). Disponible en: https://piper.espacio-seram.com/index.php/seram/article/view/4487

  9. Fernández Lobo V, Lamprecht Y, Marco De Lucas E, Drake Pérez M, Herrera Romero E, Pozo Piñón F. Encefalitis aguda y complicaciones. Encefalitis autoinmunes. La importancia del tiempo. Seram [Internet]. 2018 [citado 28/04/2022]; 2(1). Disponible en: https://piper.espacio-seram.com/index.php/seram/article/view/7414

  10. Collao Parra JP, Romero Urra C, Delgado Derio C. Encefalitis autoinmunes: criterios diagnósticos y pautas terapéuticas. Rev Med Chile [Internet]. 2018 [citado 28/04/2022]; 146:351-361. Disponible en: https://www.google.com/url?sa=t&source=web&rct=j&url=https://scielo.conicyt.cl/pdf/rmc/v146n3/0034-9887-rmc-146-03-0351.pdf&ved=2ahUKEwjwqpaYk7v3AhWQqXIEHc6NDUUQFnoECAoQAQ&sqi=2&usg=AOvVaw27lx1CboxyqbUBDIfjvoMu

  11. Torres-Ballesteros V, Murcia- Rojas D, Ochoa-Urrea M, Vargas-Osorio J, Bernal-Pacheco O, Moreno-Moreno J. Las diferentes facetas de la encefalitis autoinmune. Acta Neurol Colomb [Internet]. 2020 [citado 28/04/2022]; 36(1):39-46. Disponible en: https://doi.org/10.22379/24224022276

  12. Zuhorn F, Graf T, Klingebiel R, Schäbitz WR, Rogalewski A. Postvaccinal Encephalitis after ChAdOx1 nCov-19. Ann Neurol [Internet]. 2021 [citado 28/04/2022]; 90(3):506-511. Disponible en: https://doi.org/1 0.1002/ana.26182

  13. Rastogi A, Bingeliene A, Strafella AP, Tang-Wai DF, Wu PE, Mandell DM. Reversible neurological and brain MRI changes following COVID-19 vaccination: A case report. J Neuroradiol [Internet]. 2022 [citado 28/04/2022]: S0150-9861(22)00107-9. Disponible en: https://doi.org/10.1016/j.neurad.2022.03.011

  14. Ruda` R, Bello L, Duffau H, Soffietti R. Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro-Oncology [Internet]. 2012 [citado 28/04/2022]; 14:iv55–iv64. Disponible en: https://doi.org/10.1093/neuonc/nos199

  15. Samudraa N, Zachariasa T, Plittb A, Legab B, Pana E. Seizures in glioma patients: An overview of incidence, etiology, and therapies. Journal of the Neurological Sciences [Internet]. 2019 [citado 28/04/2022]; 404:80–85. Disponible en: https://doi.org/10.1016/j.jns.2019.07.026

  16. Frey N, Bodmer M, Bircher A, Jick SS, Meier CR, Spoendlin J. Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti‑Epileptic Drugs and Antibiotics: A Population‑Based Case–Control Study. Drug Saf [Internet]. 2019 [citado 28/04/2022]; 42(1):55–66. Disponible en: https://doi.org/10.1007/s40264-018-0711-x

  17. Frey N, Bodmer M, Bircher A, Rüegg S, Jick SS, Meier CR, et al. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs. Epilepsia [Internet]. 2017 [citado 28/04/2022]; 58(12):2178-2158. Disponible en: https://doi.org/10.1111/epi.13925




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Invest Medicoquir. 2023;15